| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |